LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 270 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $236,229,000 | -27.2% | 2,100 | 0.0% | 0.06% | -23.5% |
| Q4 2021 | $324,366,000 | -3.0% | 2,100 | -12.5% | 0.08% | -12.0% |
| Q3 2021 | $334,368,000 | -5.6% | 2,400 | -11.1% | 0.09% | +2.2% |
| Q2 2021 | $354,213,000 | -19.9% | 2,700 | -6.9% | 0.09% | -24.4% |
| Q1 2021 | $442,105,000 | +38.9% | 2,900 | -9.4% | 0.12% | +33.7% |
| Q4 2020 | $318,240,000 | +497.8% | 3,200 | +536.2% | 0.09% | +790.0% |
| Q1 2017 | $53,238,000 | -66.3% | 503 | -67.6% | 0.01% | -66.7% |
| Q4 2016 | $157,800,000 | -66.0% | 1,553 | -65.9% | 0.03% | -63.0% |
| Q3 2016 | $464,679,000 | -32.3% | 4,553 | -20.9% | 0.08% | -31.9% |
| Q2 2016 | $686,160,000 | +13.3% | 5,753 | +1.8% | 0.12% | +6.2% |
| Q1 2016 | $605,380,000 | -30.6% | 5,653 | -29.8% | 0.11% | -25.3% |
| Q4 2015 | $872,781,000 | +4.5% | 8,050 | -17.4% | 0.15% | +37.6% |
| Q3 2015 | $835,088,000 | – | 9,750 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 1,199,766 | $130,078,630,000 | 35.65% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 852,053 | $92,380,000 | 5.34% |
| OBERWEIS ASSET MANAGEMENT INC/ | 101,127 | $10,964,000 | 3.08% |
| Timpani Capital Management LLC | 68,160 | $7,390,000 | 3.00% |
| ASHFORD CAPITAL MANAGEMENT INC | 103,420 | $11,213,000 | 2.64% |
| First Light Asset Management, LLC | 56,818 | $6,160,000 | 2.58% |
| Conestoga Capital Advisors, LLC | 286,162 | $31,026,000 | 2.51% |
| OAK RIDGE INVESTMENTS LLC | 955,599 | $103,606,000 | 2.48% |
| RK Capital | 127,983 | $13,876,000 | 2.42% |
| Nichols Asset Management LLC | 93,170 | $10,101,000 | 2.20% |